Current Report Filing (8-k)
July 24 2018 - 6:37AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM
8-K
CURRENT REPORT
Pursuant to Section 13 OR
15(d) of The Securities Exchange Act of 1934
Date of Report
(Date of earliest event reported):
July
24, 2018
Medidata
Solutions, Inc.
(Exact name of registrant as specified in
its charter)
Delaware
(State or other jurisdiction
of
incorporation)
|
001-34387
(Commission
File Number)
|
13-4066508
(IRS Employer
Identification No.)
|
350 Hudson Street, 9th Floor
New York, New York
(Address of principal executive
offices)
|
10014
(Zip Code)
|
Registrant’s telephone number, including area code:
(212)
918-1800
Not Applicable
(Former name or former address, if
changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any
of the following provisions:
⃞
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
⃞
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
⃞
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
⃞
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934
(§240.12b-2 of this chapter).
Emerging growth company
⃞
If an emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying with
any new or revised financial accounting standards provided pursuant to
Section 13(a) of the Exchange Act.
⃞
Item 2.02. Results of Operations and Financial Condition.
On July 24, 2018, Medidata Solutions, Inc. issued a press release
announcing its financial results for the quarter ended June 30, 2018. A
copy of the press release is furnished herewith as Exhibit 99.1, and is
incorporated herein by reference.
In accordance with General Instruction B.2 of Form 8-K, the information
in this Current Report on Form 8-K, including the exhibits, shall not be
deemed to be “filed” for purposes of Section 18 of the Securities
Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise
subject to the liabilities of that section, and shall not be
incorporated by reference into any registration statement or other
document filed under the Securities Act of 1933, as amended, or the
Exchange Act, except as shall be expressly set forth by specific
reference in such filing.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
99.1 Press release issued by Medidata Solutions, Inc. on July 24,
2018, furnished herewith.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
|
MEDIDATA SOLUTIONS, INC.
|
|
|
Date: July 24, 2018
|
|
|
|
|
By:
|
/s/ MICHAEL I. OTNER
|
|
Name:
|
|
Michael I. Otner
|
|
Title:
|
|
Executive Vice President, General Counsel and Secretary
|
EXHIBIT INDEX
Medidata Solutions (NASDAQ:MDSO)
Historical Stock Chart
From Mar 2024 to Apr 2024
Medidata Solutions (NASDAQ:MDSO)
Historical Stock Chart
From Apr 2023 to Apr 2024